Fortis Malar Hospitals Limited carries a market capitalization of 968.95M, placing it among publicly traded companies globally. Its enterprise value stands at 368.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 968.95M |
| Enterprise Value | 368.95M |
Fortis Malar Hospitals Limited currently has 18.74M shares outstanding.
| Shares Outstanding | 18.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Fortis Malar Hospitals Limited trades at a trailing price-to-earnings ratio of 17.84. The price-to-sales ratio is 3,599.87, and the price-to-book ratio stands at 3.93.
| PE Ratio | 17.84 |
| PS Ratio | 3,599.87 |
| PB Ratio | 3.93 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
The EV/Sales ratio of 1,799.77 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.05 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1,799.77 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 12.05 |
| EV / FCF | N/A |
Fortis Malar Hospitals Limited maintains a current ratio of 11.33, meaning it holds 11.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.33 |
| Quick Ratio | 11.33 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Fortis Malar Hospitals Limited posts a return on equity of 21.00 and a return on invested capital of 8.30.
| Return on Equity (ROE) | 21.00 |
| Return on Assets (ROA) | 11.12 |
| Return on Invested Capital (ROIC) | 8.30 |
| Return on Capital Employed (ROCE) | 21.00 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Fortis Malar Hospitals Limited has paid 5.89M in income taxes, reflecting an effective tax rate of 12.45.
| Income Tax | 5.89M |
| Effective Tax Rate | 12.45 |
Fortis Malar Hospitals Limited's stock has declined approximately -27.91411% over the past 52 weeks. The 50-day moving average sits at 53.98, while the 200-day moving average is 57.60.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.91411% |
| 50-Day Moving Average | 53.98 |
| 200-Day Moving Average | 57.60 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Fortis Malar Hospitals Limited generated 205,000.00 in revenue and converted that into 41.37M in net income, yielding earnings per share of 2.34. EBITDA reached 30.61M, while operating income came in at 30.61M.
| Revenue | 205,000.00 |
| Gross Profit | 205,000.00 |
| Operating Income | 30.61M |
| Pretax Income | 47.26M |
| Net Income | 41.37M |
| EBITDA | 30.61M |
| EBIT | 30.61M |
| Earnings Per Share (EPS) | 2.34 |
Total book value stands at 187.57M, with working capital of 336.45M providing operational flexibility.
| Cash & Cash Equivalents | 369.02M |
| Total Debt | N/A |
| Net Debt | -12.86M |
| Equity (Book Value) | 187.57M |
| Book Value Per Share | 10.60 |
| Working Capital | 336.45M |
Fortis Malar Hospitals Limited operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 14,932.20 and net profit margin of 20,181.95 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 14,932.20 |
| Pretax Margin | 23,053.17 |
| Profit Margin | 20,181.95 |
| EBITDA Margin | 14,932.20 |
Fortis Malar Hospitals Limited posts an Altman Z-Score of 14.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.94 |